Asterand Awarded $6.5M Contract to Provide Tumor Samples, Data to NIH | GenomeWeb

NEW YORK (GenomeWeb) – Asterand Bioscience announced today that it has received a five-year, $6.5 million contract from the National Institutes of Health to provide oncology specimens and associated clinical data to the National Cancer Institute's Clinical Proteomic Tumor Analysis Consortium (CPTAC).

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.